Increased phospholylated Smad 2 in human eosinophils stimulated by IL-5

T. Okada, H. Sagara, M. Ota, K. Sugiyama, T. Fukuda (Mibu, Japan)

Source: Annual Congress 2004 - Inflammation and tissue repair in pulmonary disease
Session: Inflammation and tissue repair in pulmonary disease
Session type: Poster Discussion
Number: 357
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Okada, H. Sagara, M. Ota, K. Sugiyama, T. Fukuda (Mibu, Japan). Increased phospholylated Smad 2 in human eosinophils stimulated by IL-5. Eur Respir J 2004; 24: Suppl. 48, 357

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
CCL5 (RANTES) inhibits TGF-β1-induced collagen production in human bronchial epithelial cells by action of Smad protein
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009

Increased TGF-β-inducible early gene (TIEG) in human eosinophils stimulated by Th-2 type inflammatory cytokines
Source: Eur Respir J 2005; 26: Suppl. 49, 659s
Year: 2005

dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells
Source: Eur Respir J 2005; 26: 795-803
Year: 2005



IgA inhibits LPS-induced IL-10 in human alveolar macrophages (HAM)
Source: Eur Respir J 2005; 26: Suppl. 49, 585s
Year: 2005

IL-4 induces Th2 cells to resist the IL-27 counterregulation by downregulating STAT1 and STAT2 phosphorylation
Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Year: 2012

Inhibitory effects of the IL-6 receptor superantagonist SANT7 on MAP kinase phosphorylation and cell proliferation induced by IL-6 and TGF-beta1 in human lung fibroblasts
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008

Rolipram inhibits eotaxin-3 releasing in human epithelial cells BEAS-2B stimulated with Th2 cytokines
Source: Eur Respir J 2007; 30: Suppl. 51, 219s
Year: 2007

The PBMC of severe asthmatics showed enhanced candida antigen induced IL-5, IL-13 and TARC production and this enhancement was inhibited by dendric cells deprition
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009

Activation of PAR-2 enhances ICAM-1 expression and IL-8 release in airway epithelial cells
Source: Eur Respir J 2002; 20: Suppl. 38, 571s
Year: 2002

The role of p-38MAPK and STAT3 in LPS-stimulated mouse alveolar macrophage
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009

Thrombin activates mitogen activated protein (MAP) kinase and activated protein-1 (AP-1) to induce interleukin-8 (IL-8) release from airway epithelial cells
Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside
Year: 2003


NF-AT and GATA3 complex mediates anti-CD3/CD28-induced IL-13 expression: effect of glucocorticoid
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008

Up-regulation of arginase in rat primary airway fibroblasts by IL-4 and IL-13
Source: Eur Respir J 2003; 22: Suppl. 45, 386s
Year: 2003

Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-alpha and Haemophilus influenzae in human bronchial epithelial cells
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

Upregulated response to chemokines in oxidative metabolism of eosinophils in asthma and allergic rhinitis
Source: Eur Respir J 2003; 21: 925-931
Year: 2003



Interleukin 10 up-regulates Smad 7 expression in cultured epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 37s
Year: 2004

Role of dexamethasone and MAPkinases ERK and p38MAPK on T-bet expression and IFNγ release in peripheral blood lymphocytes from atopic asthmatics
Source: Eur Respir J 2006; 28: Suppl. 50, 229s
Year: 2006

Eosinophil outer membrane integrins and IL-5, IL-3, GM-CSF receptors expression in severe eosinophilic asthma
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018

Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020


PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model
Source: Annual Congress 2011 - Animal models of airway inflammation
Year: 2011